Seminars & Conferences

PRISYM ID IS SPONSOR AND EXHIBITOR AT THE 8TH ANNUAL UDI CONFERENCE

We are attending the FDA led 8th Annual UDI Conference at the Hilton Baltimore, US on the 18th and 19th April 2016. Also we’ll be sponsoring the event as well as exhibiting our market leading la-beling platform, PRISYM 360, which helps organizations in the medical device industry increase operational efficiency, reduce costs and achieve compliance.

8th-conferneceThe FDA UDI Regulation establishes a single device identification system that is globally harmo-nized and consistent. All manufacturers of medical devices are required to comply with the new UDI methodology with the aim of increasing patient safety and helping optimize patient care. The UDI Conference is the only event dedicated to supporting and training those facing imminent com-pliance deadline dates.

In recent research, we have examined how preparing for UDI compliance has impacted medical device manufacturers to date, with particular consideration of the complexities of the transition and the associated labeling challenges. Of the companies sampled, our survey revealed that only 40% of companies polled are confident that they are ready for an FDA inspection that includes UDI ac-tivities and a third believe they’re not ready.

The conference will feature a variety of seminars and presentations further examining the promi-nent issues addressed in the survey. Vince Postill, SVP of Global Product & Business Development and  Kevin Grygiel, VP of US Sales at PRISYM ID will be attending.

The UDI Conference is attended by medical device manufacturers, distributors and healthcare in-dustry professionals. Delegates will discuss the current and future success of the UDI regulation goals including:
•    Reduction of medical errors
•    Reduced recall of medical devices
•    Better compliance with the FDA UDI Regulation

Vince comments: “The UDI Conference is a valuable opportunity for the PRISYM team to discuss with industry peers how UDI is making a difference, but also, for us to share how our solutions are helping clients manage the compliance process. With regulations becoming increasingly complex, it’s ever more important for labeling solutions to facilitate streamlined, end-to-end workflows and processes that suit the unique needs of medical device organizations.”

DOWNLOAD OUR WHITEPAPER ‘HOW THE GUDID WAS IT FOR YOU?

 Read our blog - FDA Regulations for Inspection - Ignoring the warning signs of non-compliance is no longer an option